Oscient Pharmaceuticals Corp

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 35 pages Amendment No. 1 to Note Amendment and Exchange Agreement Dated as of January 28, 2009 Article XV Additional Exchange Privileges
12/34/56
EX-10.45
from S-4/A 17 pages First Amendment to the Revenue Interests Assignment Agreement
12/34/56
EX-10.45
from S-4 4 pages July 28, 2008 Mark A. Glickman 14 Exeter Drive Marlboro, Nj 07746 Re: Second Amendment to Employment Agreement Dear Mark
12/34/56
EX-10.44
from S-4 1 page Mark A. Glickman 14 Exeter Drive Marlboro, Nj 07746 Re: First Amendment to Employment Agreement Dear Mark
12/34/56
EX-10.43
from S-4 12 pages Agreement
12/34/56
EX-10.40
from S-4 50 pages Revenue Interests Assignment Agreement Dated as of July 21, 2006 and Restated as of August 18, 2006 Between Oscient Pharmaceuticals Corporation, Guardian II Acquisition Corporation and Paul Royalty Fund Holdings II
12/34/56
EX-10.1
from 10-Q 1 page April 18, 2008 Philippe Maitre 1228 Great Oaks Drive Wilmington, Nc 28405 Re: Second Amendment to Employment Agreement Dear Philippe
12/34/56
EX-10.44
from 10-K 57 pages License, Supply and Marketing Agreement
12/34/56
EX-10.43
from 10-K 11 pages Amendment No. 7 to License & Option Agreement
12/34/56
EX-10.5
from 10-K 106 pages Bay Colony Corporate Center Waltham, Massachusetts Office Lease Bay Colony Corporate Center LLC, a Delaware Limited Liability Company, Landlord and Oscient Pharmaceuticals Corporation, a Massachusetts Corporation, Tenant Dated as Of: June 23, 2004
12/34/56
EX-10.5
from 10-Q 1 page Sincerely, /S/ Joseph Pane Joe Pane Vice President Human Resources Agreed and Acknowledged: /S/ Gary Patou Gary Patou, M.D
12/34/56
EX-10.4
from 10-Q 21 pages Common Stock and Warrant Purchase Agreement Dated as of July 21, 2006 Between Oscient Pharmaceuticals Corporation and Paul Royalty Fund Holdings II
12/34/56
EX-10.3
from 10-Q 29 pages Guardian II Acquisition Corporation $20,000,000 12% Senior Secured Note Note Purchase Agreement Dated as of July 21, 2006
12/34/56
EX-10.2
from 10-Q 50 pages Revenue Interests Assignment Agreement Dated as of July 21, 2006 and Restated as of August 18, 2006 Between Oscient Pharmaceuticals Corporation, Guardian II Acquisition Corporation and Paul Royalty Fund Holdings II
12/34/56
EX-10.1
from 10-Q 50 pages Supply, Distribution and Marketing Agreement
12/34/56
EX-10.1
from 8-K/A 72 pages Amended and Restated Development, License and Supply Agreement Dated as of July 31, 2006 Between Ethypharm, S.A. 194 Bureaux De La Colline 92213 Saint Cloud France and Reliant Pharmaceuticals, Inc. 110 Allen Road Liberty Corner, New Jersey 07938 United States
12/34/56
EX-10.4
from 10-Q 6 pages This Letter Agreement Constitutes the Second Amendment and Restatement of the Original Letter Agreement of Employment Between You and Oscient Pharmaceuticals Corporation (The “Company”), Then Known as Genome Therapeutics Corporation, (Which Letter Agreement of June 15, 2001, First Amended and Restated as of February 27, 2003, Is Hereafter Referred to as the “Original Agreement”). This Second Amended and Restated Agreement (This “Agreement”) Is as Follows: 1. Position and Duties
12/34/56
EX-10.3
from 10-Q 4 pages Dominick Colangelo, Esq. 81 Tyler Road Weston, Ma 02493 Re: First Amendment to Employment Agreement Dear Nick
12/34/56
EX-10.2
from 10-Q 3 pages Mr. Steven M. Rauscher 47 Cary Avenue Lexington, Ma 02451 Re: Second Amendment to Employment Agreement Dear Steve
12/34/56
EX-10.1
from 10-Q 11 pages Agreement
12/34/56